SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-147481
Filing Date
2020-05-20
Accepted
2020-05-20 17:15:40
Documents
15
Period of Report
2020-05-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d906342d8k.htm   iXBRL 8-K 33863
2 EX-1.1 d906342dex11.htm EX-1.1 182404
3 EX-5.1 d906342dex51.htm EX-5.1 5510
4 EX-99.1 d906342dex991.htm EX-99.1 8686
  Complete submission text file 0001193125-20-147481.txt   405418

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mrna-20200518.xsd EX-101.SCH 3073
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrna-20200518_lab.xml EX-101.LAB 17374
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrna-20200518_pre.xml EX-101.PRE 10955
12 EXTRACTED XBRL INSTANCE DOCUMENT d906342d8k_htm.xml XML 3228
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

IRS No.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38753 | Film No.: 20898989
SIC: 2836 Biological Products, (No Diagnostic Substances)